158 related articles for article (PubMed ID: 34952822)
1. Sex Differences in the Clinical Outcomes After Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis.
Abusnina W; Latif A; Al-Abdouh A; Mostafa MR; Radaideh Q; Alshebani Y; Aboeata A; Ben-Dor I; Michos ED; Dahal K
Cardiovasc Revasc Med; 2022 Aug; 41():29-34. PubMed ID: 34952822
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
[TBL] [Abstract][Full Text] [Related]
3. Sex Differences in Periprocedural and Long-Term Outcomes Following Transcatheter Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis.
Mathai SV; Sohal S; Flatow E; Nagaraj S; Hajra A; Chugh Y; Palaiodimos L; Lee HJ; Ansari J; Cohen M; Volgman AS; Faillace R
Cardiovasc Revasc Med; 2023 Mar; 48():23-31. PubMed ID: 36336589
[TBL] [Abstract][Full Text] [Related]
4. Sex-related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registry.
Paitazoglou C; Eitel I; Stiermaier T; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Vireca E; Wohlmuth P; Lucas B; Bergmann MW;
Catheter Cardiovasc Interv; 2023 Aug; 102(2):283-292. PubMed ID: 37393575
[TBL] [Abstract][Full Text] [Related]
5. Sex Differences in Safety and Effectiveness of LAAO: Insights From the Amulet IDE Trial.
Alkhouli M; Russo AM; Thaler D; Windecker S; Anderson JA; Gage R; Lakkireddy D
JACC Cardiovasc Interv; 2022 Nov; 15(21):2143-2155. PubMed ID: 36357018
[TBL] [Abstract][Full Text] [Related]
6. Sex differences on outcomes following left atrial appendage occlusion in atrial fibrillation: A systematic review and meta-analysis.
Zhu Y; Sasmita BR; Xue Y; Jiang Y; Huang B; Luo S
Catheter Cardiovasc Interv; 2022 Oct; 100(4):612-619. PubMed ID: 35801485
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
Bing S; Chen RR
Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous left atrial appendage occlusion in mitral valve disease: A Nationwide Readmission Database analysis.
Feroze R; Ullah W; Kang P; Lobo T; Alhabdan N; Alghammass M; Yoon SH; Dallan LAP; Filby SJ
Cardiovasc Revasc Med; 2024 Jun; 63():23-30. PubMed ID: 38267285
[TBL] [Abstract][Full Text] [Related]
9. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.
Aarnink EW; Maarse M; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zieliński K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; Pérez de Prado A; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Millan X; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; Peper J; van Dijk VF; Rensing BJWM; Swaans MJ; Vireca E; Bergmann MW; Boersma LVA;
JACC Cardiovasc Interv; 2024 Jun; 17(11):1311-1321. PubMed ID: 38795093
[TBL] [Abstract][Full Text] [Related]
10. Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study.
Waranugraha Y; Lin LY; Tsai CT
Trends Cardiovasc Med; 2024 May; 34(4):225-233. PubMed ID: 36775218
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis.
Zhu MZ; Song H; Song GM; Bai X
Pacing Clin Electrophysiol; 2022 Oct; 45(10):1237-1247. PubMed ID: 35933600
[TBL] [Abstract][Full Text] [Related]
13. Periprocedural Outcomes Associated With Use of a Left Atrial Appendage Occlusion Device in China.
Su F; Gao C; Liu J; Ning Z; He B; Liu Y; Xu Y; Yang B; Li Y; Zhang J; Zhao X; Zhang Y; Hu H; Du X; Xie R; Zhou L; Zeng J; Ruan Z; Liu H; Guo J; Wang R; Garg S; Soliman O; Holmes DR; Serruys PW; Tao L
JAMA Netw Open; 2022 May; 5(5):e2214594. PubMed ID: 35639378
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex.
Zeitler EP; Kearing S; Coylewright M; Nair D; Hsu JC; Darden D; O'Malley AJ; Russo AM; Al-Khatib SM
Circulation; 2023 Feb; 147(7):586-596. PubMed ID: 36780379
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation.
Noseworthy PA; Van Houten HK; Krumholz HM; Kent DM; Abraham NS; Graff-Radford J; Alkhouli M; Henk HJ; Shah ND; Gersh BJ; Friedman PA; Holmes DR; Yao X
J Am Heart Assoc; 2022 Oct; 11(19):e027001. PubMed ID: 36172961
[TBL] [Abstract][Full Text] [Related]
16. Meta-Analysis of the Outcomes of Peri-Device Leak After Left Atrial Appendage Closure.
Mostafa MR; Eid MM; Abuelazm M; Al-Abdouh A; Najim M; Hassan AR; El-Sakka AA; Renjithal SLM; Malik MA; Mohamed S; Balmer-Swain M; Paul TK; Goldsweig AM
Am J Cardiol; 2023 Oct; 204():325-332. PubMed ID: 37572568
[TBL] [Abstract][Full Text] [Related]
17. Direct Oral Anticoagulant Versus Warfarin After Left Atrial Appendage Closure With WATCHMAN: Updated Systematic Review and Meta-analysis.
Tan BE; Wong PY; Lee JZ; Tan NY; Rao M; Cheung JW
Curr Probl Cardiol; 2022 Nov; 47(11):101335. PubMed ID: 35872052
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes of Left Atrial Appendage Occlusion Versus Switch of Direct Oral Antcoagulant in Atrial Fibrillation: A Territory-Wide Retrospective Analysis.
Ng AK; Ng PY; Ip A; Fung RC; Chui SF; Siu CW; Yan BP
J Am Heart Assoc; 2023 Oct; 12(20):e029421. PubMed ID: 37804191
[TBL] [Abstract][Full Text] [Related]
19. Left atrial appendage occlusion in atrial fibrillation for stroke prevention: A systemic review.
Zhou X; Zhang W; Lv W; Zhou Q; Li Y; Zhang L; Lu Y; Zhang J; Xing Q; Wang H; Tang B
Int J Cardiol; 2016 Jan; 203():55-9. PubMed ID: 26492310
[TBL] [Abstract][Full Text] [Related]
20. Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices.
Price MJ; Friedman DJ; Du C; Wang Y; Lin Z; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 Nov; 15(21):2115-2123. PubMed ID: 36357014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
